• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性黑色素瘤患者的特异性 CD8(+) T 细胞能够直接在体外进行抗原特异性脱颗粒和细胞溶解。

Human melanoma-specific CD8(+) T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo.

机构信息

Ludwig Center for Cancer Research; University of Lausanne; Lausanne, Switzerland.

出版信息

Oncoimmunology. 2012 Jul 1;1(4):467-530. doi: 10.4161/onci.19856.

DOI:10.4161/onci.19856
PMID:22754765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3382891/
Abstract

The relatively low frequencies of tumor Ag-specific T-cells in PBMC and metastases from cancer patients have long precluded the analysis of their direct ex vivo cytolytic capacity. Using a new composite technique that works well with low cell numbers, we aimed at determining the functional competence of melanoma-specific CD8(+) T-cells. A multiparameter flow cytometry based technique was applied to assess the cytolytic function, degranulation and IFNγ production by tumor Ag-specific CD8(+) T-cells from PBMC and tumor-infiltrated lymph nodes (TILN) of melanoma patients. We found strong cytotoxicity by T-cells not only when they were isolated from PBMC but also from TILN. Cytotoxicity was observed against peptide-pulsed target cells and melanoma cells presenting the naturally processed endogenous antigen. However, unlike their PBMC-derived counterparts, T-cells from TILN produced only minimal amounts of IFNγ, while exhibiting similar levels of degranulation, revealing a critical functional dichotomy in metastatic lesions. Our finding of partial functional impairment fits well with the current knowledge that T-cells from cancer metastases are so-called exhausted, a state of T-cell hyporesponsiveness also found in chronic viral infections. The identification of responsible mechanisms in the tumor microenvironment is important for improving cancer therapies.

摘要

在 PBMC 和癌症转移部位中,肿瘤 Ag 特异性 T 细胞的相对低频长期以来排除了对其直接离体细胞毒性能力的分析。使用一种新的复合技术,该技术在细胞数量较少的情况下效果很好,我们旨在确定黑色素瘤特异性 CD8(+) T 细胞的功能能力。应用一种基于多参数流式细胞术的技术来评估来自黑色素瘤患者 PBMC 和肿瘤浸润淋巴结 (TILN) 的肿瘤 Ag 特异性 CD8(+) T 细胞的细胞毒性、脱颗粒和 IFNγ 产生。我们发现 T 细胞不仅在从 PBMC 分离时而且在从 TILN 分离时具有很强的细胞毒性。当它们针对肽脉冲靶细胞和呈现天然加工的内源性抗原的黑色素瘤细胞时观察到细胞毒性。然而,与 PBMC 衍生的对应物不同,来自 TILN 的 T 细胞仅产生少量 IFNγ,同时表现出相似水平的脱颗粒,揭示了转移性病变中关键的功能二分法。我们发现的部分功能障碍与当前的知识相符,即来自癌症转移的 T 细胞是所谓的耗竭的,这种 T 细胞低反应性状态也存在于慢性病毒感染中。在肿瘤微环境中确定负责的机制对于改善癌症治疗很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/b85bcaf09a4c/onci-1-467-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/b1a81f316c54/onci-1-467-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/66bd0566ff53/onci-1-467-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/76cfc31a6605/onci-1-467-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/c391acae4400/onci-1-467-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/b85bcaf09a4c/onci-1-467-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/b1a81f316c54/onci-1-467-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/66bd0566ff53/onci-1-467-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/76cfc31a6605/onci-1-467-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/c391acae4400/onci-1-467-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/3382891/b85bcaf09a4c/onci-1-467-g5.jpg

相似文献

1
Human melanoma-specific CD8(+) T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo.转移性黑色素瘤患者的特异性 CD8(+) T 细胞能够直接在体外进行抗原特异性脱颗粒和细胞溶解。
Oncoimmunology. 2012 Jul 1;1(4):467-530. doi: 10.4161/onci.19856.
2
Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.在原发性和转移性黑色素瘤的肿瘤部位鉴定到肿瘤反应性 CD8+早期效应 T 细胞。
Cancer Res. 2010 Nov 1;70(21):8378-87. doi: 10.1158/0008-5472.CAN-10-2028. Epub 2010 Sep 21.
3
Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination.接受多疗程肽疫苗接种患者中肿瘤抗原反应性CD8 + T淋巴细胞的表型和功能成熟
J Immunother. 2004 Jan-Feb;27(1):36-47. doi: 10.1097/00002371-200401000-00004.
4
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.TCRβ链使用情况的四聚体引导分析揭示了黑色素瘤患者中大量的黑色素A特异性CD8 + T细胞库。
J Immunol. 2000 Jul 1;165(1):533-8. doi: 10.4049/jimmunol.165.1.533.
5
Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood.无瘤疫苗引流淋巴结和外周血中I类限制性gp100黑色素瘤肽刺激的原发性免疫反应的特征分析
Clin Cancer Res. 2009 Apr 1;15(7):2541-51. doi: 10.1158/1078-0432.CCR-08-2806. Epub 2009 Mar 24.
6
The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays.在干扰素-γ酶联免疫斑点试验中,使用转染了HLA-A*0201的K562细胞作为CD8(+) T淋巴细胞的标准抗原呈递细胞。
J Immunol Methods. 2002 Jan 1;259(1-2):95-110. doi: 10.1016/s0022-1759(01)00499-9.
7
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.循环中人类肿瘤特异性 CD8 T 细胞的疫苗诱导功能能力。
Int J Cancer. 2012 Jun 1;130(11):2607-17. doi: 10.1002/ijc.26297. Epub 2011 Aug 24.
8
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.黑色素瘤患者体内循环的肿瘤反应性CD8(+) T细胞包含一个CD45RA(+)CCR7(-)效应子亚群,该亚群在体外具有肿瘤特异性细胞溶解活性。
Cancer Res. 2002 Mar 15;62(6):1743-50.
9
Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.负载凋亡肿瘤细胞的树突状细胞可诱导针对B16黑色素瘤的长期保护性CD4+和CD8+ T细胞免疫。
J Immunol. 2003 Dec 1;171(11):5940-7. doi: 10.4049/jimmunol.171.11.5940.
10
IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.白细胞介素-12控制一类新型自身抗原特异性人类CD28⁺ 细胞毒性T细胞的细胞毒性。
J Immunol. 2007 Mar 15;178(6):3566-74. doi: 10.4049/jimmunol.178.6.3566.

引用本文的文献

1
Multiple outcomes of the germline p16 mutation affecting senescence and immunity in human skin.种系p16突变对人类皮肤衰老和免疫的多种影响
Aging Cell. 2025 Feb;24(2):e14373. doi: 10.1111/acel.14373. Epub 2024 Oct 17.
2
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity.DGKα/ζ 抑制降低 TCR 亲和力阈值并增强抗肿瘤免疫。
Sci Adv. 2023 Nov 24;9(47):eadk1853. doi: 10.1126/sciadv.adk1853.
3
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses.

本文引用的文献

1
The three main stumbling blocks for anticancer T cells.抗肿瘤 T 细胞的三大障碍。
Trends Immunol. 2012 Jul;33(7):364-72. doi: 10.1016/j.it.2012.02.006. Epub 2012 Mar 23.
2
Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.黑色素瘤患者转移灶中肿瘤特异性 CD8+T 细胞耗竭。
J Clin Invest. 2011 Jun;121(6):2350-60. doi: 10.1172/JCI46102. Epub 2011 May 9.
3
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.采用 T 细胞转移免疫疗法治疗转移性黑色素瘤的大量预处理患者中持久的完全应答。
追求卓越:TCR 亲和力、亲合力和功能亲合力如何影响 TCR 工程化 T 细胞抗肿瘤反应。
Cells. 2020 Jul 18;9(7):1720. doi: 10.3390/cells9071720.
4
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).流式细胞术和细胞分选在免疫学研究中的应用指南(第二版)。
Eur J Immunol. 2019 Oct;49(10):1457-1973. doi: 10.1002/eji.201970107.
5
Back from the dead: TIL apoptosis in cancer immune evasion.起死回生:肿瘤浸润淋巴细胞凋亡与肿瘤免疫逃逸
Br J Cancer. 2018 Feb 6;118(3):309-311. doi: 10.1038/bjc.2017.483. Epub 2018 Jan 23.
6
Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients.鉴定中国白癜风患者中新的 HLA-A*0201 限制性 CTL 表位。
Sci Rep. 2016 Nov 8;6:36360. doi: 10.1038/srep36360.
7
A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor Cells.一个用于研究细胞毒性T淋巴细胞与肿瘤细胞相互作用的良好控制的实验系统。
Front Immunol. 2016 Aug 30;7:326. doi: 10.3389/fimmu.2016.00326. eCollection 2016.
8
T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?慢性感染和癌症中的 T 细胞分化:功能适应还是衰竭?
Nat Rev Immunol. 2014 Nov;14(11):768-74. doi: 10.1038/nri3740. Epub 2014 Sep 26.
9
Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.检测肿瘤相关抗原在肽脉冲 T2 细胞上的呈现。
Oncoimmunology. 2013 Nov 1;2(11):e26840. doi: 10.4161/onci.26840. Epub 2013 Oct 21.
10
Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells.抑制性受体表达更多地取决于人类 CD8+T 细胞的分化和激活,而不是“耗竭”。
Front Immunol. 2013 Dec 19;4:455. doi: 10.3389/fimmu.2013.00455. eCollection 2013.
Clin Cancer Res. 2011 Jul 1;17(13):4550-7. doi: 10.1158/1078-0432.CCR-11-0116. Epub 2011 Apr 15.
4
SPICE: exploration and analysis of post-cytometric complex multivariate datasets.SPICE:用于分析和探索细胞后多维复杂数据集的工具。
Cytometry A. 2011 Feb;79(2):167-74. doi: 10.1002/cyto.a.21015. Epub 2011 Jan 7.
5
Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF.HIV 特异性 CD8+ T 细胞的转录分析表明,PD-1 通过上调 BATF 抑制 T 细胞功能。
Nat Med. 2010 Oct;16(10):1147-51. doi: 10.1038/nm.2232. Epub 2010 Oct 3.
6
The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.TCR/pMHC相互作用的持续时间调节CTL效应功能和肿瘤杀伤能力。
Eur J Immunol. 2009 Aug;39(8):2259-69. doi: 10.1002/eji.200939341.
7
Cell death mechanisms induced by cytotoxic lymphocytes.细胞毒性淋巴细胞诱导的细胞死亡机制。
Cell Mol Immunol. 2009 Feb;6(1):15-25. doi: 10.1038/cmi.2009.3.
8
Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.通过联合阻断PD-1/CTLA-4协同逆转肝内丙型肝炎病毒特异性CD8 T细胞耗竭
PLoS Pathog. 2009 Feb;5(2):e1000313. doi: 10.1371/journal.ppat.1000313. Epub 2009 Feb 27.
9
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.肿瘤相关巨噬细胞在肿瘤进展和免疫监视中的阴阳学说
Immunol Rev. 2008 Apr;222:155-61. doi: 10.1111/j.1600-065X.2008.00607.x.
10
Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice.小鼠过继性T细胞治疗期间肿瘤内CD8 + T细胞细胞毒性活性的双光子成像
J Clin Invest. 2008 Apr;118(4):1390-7. doi: 10.1172/JCI34388.